Hypomethylation status of miR-657 promoter region as biomarker for diagnosis of hepatocellular carcinoma: a retrospective study

BACKGROUND: The purpose of our study was to evaluate whether the methylation status of the miR-657 promoter region could be used as a biomarker for diagnosis of hepatocellular carcinoma (HCC), so as to find alternative biomarkers of early HCC detection. METHODS: Cancerous and paired adjacent noncanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Zhaoqi, Luo, Peng, Fan, Xiaoxiao, Pan, Junhai, He, Lifeng, Zhou, Daizhan, Lin, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189178/
https://www.ncbi.nlm.nih.gov/pubmed/35706811
http://dx.doi.org/10.21037/tcr-21-2621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189178/
https://www.ncbi.nlm.nih.gov/pubmed/35706811
http://dx.doi.org/10.21037/tcr-21-2621

Ejemplares similares